Calcium Antagonists Clinical Use in the Treatment of Arrhythmias

Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial Infarction

1981 • 1,594 citations

Verapamil

1978 • 829 citations

Demonstration of Dual A-V Nodal Pathways in Patients with Paroxysmal Supraventricular Tachycardia

1973 • 537 citations

Demonstration of a Dual A-V Nodal Conduction System in the Isolated Rabbit Heart

1966 • 355 citations

Cellular mechanisms for cardiac arrhythmias.

1981 • 354 citations

Immediate Effects of Intravenous Verapamil in Cardiac Arrhythmias

1972 • 311 citations

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

1972 • 294 citations

Effect of Verapamil on the Sinoatrial and Atrioventricular Nodes of the Rabbit and the Mechanism by Which it Arrests Reentrant Atrioventricular Nodal Tachycardia

1974 • 285 citations

Effects of Agents which Inhibit the Slow Channel on Sinus Node Automaticity and Atrioventricular Conduction in the Dog

1974 • 284 citations

Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.

1980 • 270 citations

Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.

1981 • 256 citations

Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.

1980 • 235 citations

Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter

1981 • 212 citations

Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.

1982 • 212 citations

The influence of verapamil on serum digoxin concentration.

1982 • 207 citations

New perspectives in the pharmacologic therapy of cardiac arrhythmias

1980 • 206 citations

Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram

1975 • 203 citations

Intravenous Verapamil for Termination of Re-Entrant Supraventricular Tachycardias

1980 • 199 citations

Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs

1977 • 198 citations

Verapamil in the treatment of paroxysmal supraventricular tachycardia

1974 • 195 citations

Electrophysiologic properties and response to pharmacologic agents of fibers from diseased human atria.

1976 • 194 citations

Prevention of ventricular fibrillation induced by coronary ligation.

1968 • 173 citations

Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia

1977 • 170 citations

Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.

1974 • 150 citations

Cellular electrophysiology of human myocardial infarction. 1. Abnormalities of cellular activation.

1979 • 144 citations

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A review

1983 • 132 citations

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study.

1979 • 126 citations

III. CALCIUM ANTAGONISTS

1980 • 123 citations

Immediate effects of intravenous verapamil on atrial fibrillation

1971 • 122 citations

Reduced verapamil clearance during long-term oral administration

1981 • 119 citations

Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis.

1981 • 118 citations

Action of verapamil on sinus node, atrioventricular, and intraventricular conduction.

1973 • 117 citations

Asystole after verapamil.

1972 • 114 citations

Oral Verapamil for Paroxysmal Supraventricular Tachycardia

1982 • 104 citations

The Beneficial Effects of Verapamil in Chronic Atrial Fibrillation

1979 • 98 citations

Verapamil in cardiology.

1974 • 97 citations

The pre-excitation syndromes.

1977 • 92 citations

Verapamil protein binding in patients and in normal subjects

1981 • 88 citations

ARRHYTHMIA AS A CAUSE OF SUDDEN DEATH IN HYPERTROPHIC CARDIOMYOPATHY

1976 • 86 citations

Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia

1982 • 86 citations

Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction.

1978 • 76 citations

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

1978 • 75 citations

Effect of verapamil in infants with paroxysmal supraventricular tachycardia.

1979 • 67 citations

Verapamil in atrial fibrillation and atrial flutter

1979 • 65 citations

Effects of verapamil on ventricular rhythm during acute coronary occlusion

1978 • 64 citations

Fluorometric Assay of Verapamil in Biological Fluids and Tissues

1976 • 63 citations

Clinical pharmacology of slow channel blocking agents

1982 • 61 citations

Effects of verapamil on supraventricular tachycardia in children

1981 • 59 citations

VERAPAMIL IN CARDIAC DYSRHYTHMIAS DURING ANAESTHESIA

1970 • 59 citations

Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia

1982 • 58 citations

Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome

1981 • 57 citations

Role of calcium antagonists in cardiovascular therapy.

1981 • 56 citations

Hemodynamic effects of verapamil and practolol in man.

1976 • 55 citations

Verapamil and Norverapamil Plasma Concentrations During Long-Term Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy

1980 • 54 citations

Verapamil in life-threatening tachyarrhythmias.

1972 • 51 citations

Verapamil in cardiac arrhythmias.

1972 • 51 citations

Electrophysiologic Effects of Diltiazem, a Calcium Antagonist, in Patients With Impaired Sinus or Atrioventricular Node Function

1980 • 49 citations

COMPARATIVE EFFICIENCY OF QUINIDINE AND VERAPAMIL IN THE MAINTENANCE OF SINUS RHYTHM AFTER DC CONVERSION OF ATRIAL FIBRILLATION A CONTROLLED CLINICAL TRIAL

1981 • 44 citations

Verapamil in cardiac arrhythmias.

1972 • 42 citations

Verapamil in Prophylaxis of Paroxysmal Atrioventricular Nodal Reentrant Tachycardia

1980 • 39 citations

Accurate rapid compact analog method for the quantification of frequency and duration of myocardial ischemia by semiautomated analysis of 24-hour Holter ECG recordings

1982 • 39 citations

Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children

1981 • 34 citations

Gas chromatographic determination of verapamil in plasma and urine.

1979 • 32 citations

Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia.

1976 • 32 citations

Verapamil‐Induced Ventricular Regularity in Atrial Fibrillation

1979 • 31 citations

Pharmacological Basis for the Therapeutic Applications of Slow-Channel Blocking Drugs

1982 • 29 citations

Treatment of Supraventricular Arrhythmias with Intravenous and Oral Verapamil

1981 • 28 citations

Influence of various antiarrhythmic drugs (Aprindine, ajmaline, verapamil, oxprenolol, orciprenaline) on functional properties of accessory A-V pathways.

1974 • 27 citations

Electrophysiologic evaluation of intravenous verapamil in man.

1977 • 24 citations

Digitalis and atrial tachycardia with block.

1974 • 22 citations

Suppression of Repeatedly Occurring Ventricular Fibrillation with Nifedipine in Variant Form of Angina Pectoris

1977 • 20 citations

Effects of verapamil in ventricular premature beats of acute myocardial infarction.

1978 • 18 citations

The effects of anti-anginal drugs on AV-conduction in normal subjects.

1974 • 18 citations

Effects of Verapamil on Accessory Pathway Properties and Induction of Circus Movement Tachycardia in Patients with the Wolff-Parkinson-White Syndrome

1981 • 17 citations

Safety and efficacy of short- and long-term verapamil therapy in children with tachycardia

1981 • 17 citations

Verapamil in the Treatment of Atrial Tachycardia with Block

1975 • 15 citations

Effect on paroxysmal re-entrant supraventricular tachycardia of a drug affecting calcium transport (Ro 11-1781)

1979 • 12 citations

The effect of a new calcium antagonist (Ro 11-1781) on the cardiac conduction system in man.

1979 • 12 citations

Verapamil in the treatment of PSVT

1981 • 11 citations

Oral verapamil in the treatment of atrial fibrillation/flutter

1982 • 11 citations

Concentration dependent heart rate suppression with verapamil

1981 • 11 citations

Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.

1980 • 10 citations

Treatment of Arrhythmias by Blocking Slow Current

1980 • 10 citations

Verapamil versus placebo in atrial fibrillation and atrial flutter.

1980 • 9 citations

[The electrophysiological effects of the Ca-antagonists gallopamil (D 600), dimeditiapramine (Ro 11-1781) and verapamil in man (author's transl)].

1980 • 8 citations

Oral verapamil as maintenance therapy after cardioversion for atrial fibrillation.

1977 • 7 citations

Clinical utility of plasma verapamil levels in patients with hypertrophic cardiomyopathy

1981 • 7 citations

Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.

1980 • 7 citations

Human electropharmacology of the calcium antagonist dimeditiapramine (Ro 11‐1781) in coronary patients

1979 • 6 citations

Calcium antagonists: long-awaited new therapy for heart disease

1981 • 6 citations

Arrhythmias in infants and children.

1981 • 5 citations

Electrophysiology and Antiarrhythmic Effects of Calcium Antagonists

1981 • 5 citations

Antiarrhythmic Effects of Verapamil

1983 • 4 citations

[Treatment of cardiac arrhythmias with Verapamil (author's transl)].

1974 • 3 citations

Calcium antagonists: mechanisms of action in arrhythmias.

1980 • 3 citations

Future Relationships of Hospitals in Population Medicine*

1973 • 3 citations

Clinical uses of calcium ion antagonists in arrhythmias.

1980 • 3 citations

Calcium antagonists and cardiac dysrhythmias.

1981 • 2 citations

Basic Mechanisms of ‘Calcium Antagonists’ (Slow Channel Blockers)

1981 • 2 citations